Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Graft-versus-host disease.

G B Vogelsang1, J E Wagner

  • 1Johns Hopkins Bone Marrow Unit, Johns Hopkins Hospital, Baltimore, Maryland.

Hematology/Oncology Clinics of North America
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation.

Transplantation and cellular therapy·2021
Same author

Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.

The British journal of dermatology·2019
Same author

In Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning.

Bone marrow transplantation·2016
Same author

Investigation of the 3-D actinic flux field in mountainous terrain.

Atmospheric research·2015
Same author

The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML.

Bone marrow transplantation·2014

Graft-versus-host disease (GVHD) remains a major cause of death after allogeneic bone marrow transplantation. This review covers GVHD pathogenesis, prediction, prophylaxis, and treatment strategies for acute and chronic forms.

Area of Science:

  • Immunology
  • Hematology
  • Transplantation Medicine

Background:

  • Graft-versus-host disease (GVHD) occurs when donor immune cells recognize the patient's tissues as foreign after allogeneic bone marrow transplantation.
  • Despite therapeutic advancements, GVHD and its treatment complications are primary causes of mortality post-transplant.

Purpose of the Study:

  • To provide a comprehensive review of graft-versus-host disease (GVHD).
  • To discuss the pathogenesis, prediction, prophylaxis, and treatment of both acute and chronic GVHD.

Main Methods:

  • Literature review of pathogenesis, prediction, prophylaxis, and treatment of GVHD.
  • Synthesis of current understanding and emerging strategies for managing acute and chronic GVHD.

Main Results:

Related Experiment Videos

  • GVHD pathogenesis involves immunologic recognition of the host by donor marrow graft.
  • Acute and chronic GVHD present distinct clinical courses and challenges.
  • Current treatments face limitations due to disease and treatment-related complications.

Conclusions:

  • Effective management of GVHD is critical for improving outcomes in allogeneic bone marrow transplantation.
  • Continued research into GVHD pathogenesis and novel therapeutic approaches is essential.
  • A multidisciplinary approach is necessary for optimal prediction, prophylaxis, and treatment of GVHD.